Publications by authors named "Colin D Godwin"

Claim this Profile
P
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms.
Colin D Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, Anna B Halpern, Jacob S Appelbaum

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy.
Colin D Godwin, George S Laszlo, Salvatore Fiorenza, Eliotte E Garling, Tinh-Doan Phi

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow.
Colin D Godwin, Yi Zhou, Megan Othus, Mallette M Asmuth, Carole M Shaw

Blood· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia.
Colin D Godwin, Olivia M Bates, Sae Rin Jean, George S Laszlo, Eliotte E Garling

Leuk Lymphoma· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm.
Raffaele Palmieri, Megan Othus, Anna B Halpern, Mary-Elizabeth M Percival, Colin D Godwin

J Clin Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia.
Colin D Godwin, George S Laszlo, Brent L Wood, Colin E Correnti, Olivia M Bates

Leukemia· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity.
Colin D Godwin, Olivia M Bates, Eliotte E Garling, Mary E Beddoe, George S Laszlo

Br J Haematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission.
Colin D Godwin, Jonathan R Fromm, Megan Othus, Brenda M Sandmaier, Marco B Mielcarek

Bone Marrow Transplant· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between CD33 expression, splicing polymorphism, and cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330.
George S Laszlo, Mary E Beddoe, Colin D Godwin, Olivia M Bates, Chelsea J Gudgeon

Haematologica· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation.
Colin E Correnti, George S Laszlo, Willem J de van der Schueren, Colin D Godwin, Ashok Bandaranayake

Leukemia· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia.
Colin D Godwin, George B McDonald, Roland B Walter

Blood· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of early death in adults with relapsed or refractory acute myeloid leukemia.
Colin D Godwin, Megan Othus, Morgan A Powell, Sarah A Buckley, Elihu H Estey

Leuk Lymphoma· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.
Roland B Walter, Brenda M Sandmaier, Barry E Storer, Colin D Godwin, Sarah A Buckley

Biol Blood Marrow Transplant· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis